Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Intuitive Surgical, Inc. (ISRG:NASDAQ), powered by AI.
Intuitive Surgical, Inc. is currently trading at $482.22. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Intuitive Surgical, Inc. on Alpha Lenz.
View Intuitive Surgical, Inc.'s valuation metrics on Alpha Lenz.
“Intuitive Surgical, Inc.'s ROE is 16.7%. Explore profitability and growth together.”
Ask for details →Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
“Intuitive Surgical, Inc.'s ROE is 16.7%. Explore profitability and growth together.”
Ask for details →Intuitive Surgical, Inc. (ticker: ISRG) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 15,638 employees.
The current price is $482.22 with a P/E ratio of -x and P/B of -x.
ROE is 16.67% and operating margin is 29.27%. Annual revenue is $10.1B.